Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°æ¿äµµ Àü¸³¼± ÀýÁ¦¼ú¿¡ ÀÇÇÑ Àü¸³¼± ºñ´ëÁõ Áõ»ó °³¼±¿¡ ´ëÇÑ Æò°¡ The Assessment of Symptomatic Improvement of Patients with Benign Prostatic Hyperplasia After Transurethral Prostatectomy

´ëÇѺñ´¢±â°úÇÐȸÁö 1992³â 33±Ç 6È£ p.1090 ~ 1094
±Ç¿µÈÄ, °­Á¤±â,
¼Ò¼Ó »ó¼¼Á¤º¸
±Ç¿µÈÄ (  ) 
¸Þ¸®³îº´¿ø

°­Á¤±â (  ) 
¸Þ¸®³îº´¿ø

Abstract


Although transurethral prostatectomy is the most common treatment method of benign prostatic hyperplasia, the exact indication and efficacy of this method is variable and controversial. We performed this study to determine the efficacy of
transurethral
prostatectomy on men with moderate symptoms of benign prostatic hyperplasia. The efficacy parameters evaluated included the change of maximal flow rate. Boyarsky symptom score and the global assessment of voiding symptom by the patient after
transurethral prostatectomy. The mean maximal flow rate improved 204% after transurethral prostatectomy, and the mean obstructive and irritative symptom scores deacresed 84% and 59% respectively. But the irritative symptom score of unsatisfied
patients
decreased only 41%. Over all, 80% of the patients were satisfied with the result of the operations. The improvement of the irritative symptoms is not expected after a transurethral prostatectomy, and therefore, the operative procedure is not
indicated.
But the symptoms of the unsatisfied patients were similar to the comparative group (healthy men over 50 years of age). Although this comparative group had nocturia (11%), frequency(32%), urgency(29%), they felt no necessity for special medical
attention, but hesitancy, intermittency, terminal dribbling and dysuria led the patient to seek help in a hospital.

Å°¿öµå

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS